Yufeng Luo

851 total citations
51 papers, 606 citations indexed

About

Yufeng Luo is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yufeng Luo has authored 51 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 13 papers in Pathology and Forensic Medicine and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yufeng Luo's work include Lung Cancer Treatments and Mutations (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Cancer Cells and Metastasis (5 papers). Yufeng Luo is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Cancer Cells and Metastasis (5 papers). Yufeng Luo collaborates with scholars based in China, United States and Australia. Yufeng Luo's co-authors include Zhiyong Liang, Shafei Wu, Huanwen Wu, Jinling Cao, Xuan Zeng, Jian Sun, Yalan Bi, Yunxiao Meng, Zhen Huo and Xiaohua Shi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Yufeng Luo

47 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yufeng Luo China 15 339 185 167 117 114 51 606
Giovanni Branca Italy 17 300 0.9× 166 0.9× 137 0.8× 129 1.1× 145 1.3× 42 668
Adriana C. H. van Engen–van Grunsven Netherlands 15 342 1.0× 127 0.7× 233 1.4× 158 1.4× 82 0.7× 37 636
Monika Vyas United States 13 209 0.6× 142 0.8× 167 1.0× 123 1.1× 120 1.1× 39 583
Max M. van Noesel Netherlands 16 291 0.9× 232 1.3× 133 0.8× 445 3.8× 125 1.1× 44 1.0k
Younghye Kim South Korea 13 251 0.7× 133 0.7× 242 1.4× 247 2.1× 180 1.6× 30 817
T Pasha United States 11 235 0.7× 155 0.8× 127 0.8× 234 2.0× 89 0.8× 12 678
R von Wasielewski Germany 8 310 0.9× 261 1.4× 241 1.4× 319 2.7× 180 1.6× 13 789
Marc Goldman United States 8 265 0.8× 109 0.6× 97 0.6× 74 0.6× 107 0.9× 11 469
Shelley A. Roberts United States 10 215 0.6× 69 0.4× 116 0.7× 71 0.6× 159 1.4× 13 479
Giovanna De Maglio Italy 15 308 0.9× 364 2.0× 109 0.7× 238 2.0× 143 1.3× 48 815

Countries citing papers authored by Yufeng Luo

Since Specialization
Citations

This map shows the geographic impact of Yufeng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufeng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufeng Luo more than expected).

Fields of papers citing papers by Yufeng Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yufeng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufeng Luo. The network helps show where Yufeng Luo may publish in the future.

Co-authorship network of co-authors of Yufeng Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Yufeng Luo. A scholar is included among the top collaborators of Yufeng Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yufeng Luo. Yufeng Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Yufeng, Yanfei Wang, Wenyan Ren, et al.. (2025). Association of habitual glucosamine use with risk of microvascular complications among individuals with type 2 diabetes: a prospective cohort study in UK biobank. Nutrition and Diabetes. 15(1). 12–12. 1 indexed citations
2.
Xu, Yuan, et al.. (2025). Hypoxia induced SH3GLB1 is required for NOTCH2 activation and glioblastoma development. Biochemical and Biophysical Research Communications. 777. 152302–152302.
3.
Luo, Yufeng, Ting He, Ping Cai, et al.. (2025). Five new triterpenoids isolated from mastic: Structural identification and their anti-inflammatory activity. Fitoterapia. 181. 106395–106395.
4.
5.
Wu, Shafei, Xiaohua Shi, Jing Wang, et al.. (2021). Triple-Negative Breast Cancer: Intact Mismatch Repair and Partial Co-Expression of PD-L1 and LAG-3. Frontiers in Immunology. 12. 561793–561793. 24 indexed citations
6.
Zhang, Cai, Yulin Deng, Ye J, et al.. (2020). Aberrant Expression of Citrate Synthase is Linked to Disease Progression and Clinical Outcome in Prostate Cancer. SHILAP Revista de lepidopterología. 3 indexed citations
7.
Liu, Yuanyuan, Shafei Wu, Xiaohua Shi, et al.. (2019). HER2 double-equivocal breast cancer in Chinese patients: a high concordance of HER2 status between different blocks from the same tumor. Breast Cancer Research and Treatment. 178(2). 275–281. 6 indexed citations
8.
Zhang, Jing, Jian Sun, Jun Feng, et al.. (2018). Primary adrenal diffuse large B cell lymphoma: a clinicopathological and molecular study from China. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 473(1). 95–103. 8 indexed citations
9.
Bi, Yalan, Yang Qu, Zhiyong Liang, et al.. (2018). Clinicopathological analysis of Large Cell Lung Carcinomas definitely diagnosed according to the New World Health Organization Criteria. Pathology - Research and Practice. 214(4). 555–559. 5 indexed citations
10.
Liang, Xiaolong, Jian Sun, Huanwen Wu, et al.. (2018). PD-L1 in pancreatic ductal adenocarcinoma: a retrospective analysis of 373 Chinese patients using an in vitro diagnostic assay. Diagnostic Pathology. 13(1). 5–5. 29 indexed citations
11.
12.
Xie, Yuan, Jianzhen Lin, Weiyu Xu, et al.. (2017). Threonine and tyrosine kinase may serve as a prognostic biomarker for gallbladder cancer. World Journal of Gastroenterology. 23(31). 5787–5787. 2 indexed citations
13.
Wu, Shafei, Yuanyuan Liu, Ying Jiang, et al.. (2015). [HER2 mRNA expression in breast cancers with equivocal immunohistochemical results using in situ mRNA hybridization].. PubMed. 44(10). 725–8. 1 indexed citations
14.
Huo, Zhen, Huanwen Wu, Ji Li, et al.. (2015). Primary Pulmonary Mucoepidermoid Carcinoma: Histopathological and Moleculargenetic Studies of 26 Cases. PLoS ONE. 10(11). e0143169–e0143169. 54 indexed citations
15.
16.
Huo, Zhen, Yunxiao Meng, Huanwen Wu, et al.. (2014). Adenoid cystic carcinoma of the tracheobronchial tree: clinicopathologic and immunohistochemical studies of 21 cases.. PubMed. 7(11). 7527–35. 34 indexed citations
17.
Sun, Jian, Jing Zhang, Qing Ling, et al.. (2014). Primary diffuse large B-cell lymphoma of the ovary is of a germinal centre B-cell-like phenotype. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 466(1). 93–100. 9 indexed citations
18.
Feng, Chao, Hanzhong Li, Weigang Yan, Yufeng Luo, & Jinling Cao. (2005). [The expression and significance of chromogranin A and synaptophysin in adrenal gland tumors].. PubMed. 27(8). 486–8. 3 indexed citations
19.
Luo, Yufeng, et al.. (2000). Fas ligand expression and apoptosis in primary rat hepatocytes induced by lipopolysaccharide.. PubMed. 8(5). 285–7. 4 indexed citations
20.
W, Liu, et al.. (2000). [Aberrant expression of MUC2 and MUC3 genes in gastric carcinoma and its significance].. PubMed. 113(6). 502–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giovanni Branca Breakdown of academic impact, for papers by Adriana C. H. van Engen–van Grunsven Breakdown of academic impact, for papers by Monika Vyas Breakdown of academic impact, for papers by Max M. van Noesel Breakdown of academic impact, for papers by Younghye Kim Breakdown of academic impact, for papers by T Pasha Breakdown of academic impact, for papers by R von Wasielewski Breakdown of academic impact, for papers by Marc Goldman Breakdown of academic impact, for papers by Shelley A. Roberts Breakdown of academic impact, for papers by Giovanna De Maglio
Rankless by CCL
2026